1. Home
  2. Analysis
  3. Prinivil
  4. Neoplasm-progression

Prinivil and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Prinivil (lisinopril), especially for people who are female, 60+ old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Prinivil. It is created by eHealthMe based on reports of 19,973 people who have side effects when taking Prinivil from the FDA, and is updated regularly.

What is Prinivil?

Prinivil has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 20,152 Prinivil users. Check the latest studies of Prinivil.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,067 drugs and 915 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

19,973 people reported to have side effects when taking Prinivil.
Among them, 48 people (0.24%) have Neoplasm progression.

Could Prinivil cause Neoplasm progression?

Among these 48 people:

What is the gender of people who have Neoplasm progression when taking Prinivil? *

  • female: 72.34 %
  • male: 27.66 %

What is the age of people who have Neoplasm progression when taking Prinivil? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.56 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 10.26 %
  • 60+: 87.18 %

What are other drugs people take besides Prinivil? *

  1. Zometa: 21 people, 43.75%
  2. Prilosec: 19 people, 39.58%
  3. Ms Contin: 19 people, 39.58%
  4. Femara: 18 people, 37.50%
  5. Aredia: 18 people, 37.50%
  6. Xeloda: 18 people, 37.50%
  7. Zestril: 15 people, 31.25%
  8. Mobic: 15 people, 31.25%
  9. Meloxicam: 13 people, 27.08%
  10. Coumadin: 13 people, 27.08%

What are other side effects people have besides Neoplasm progression? *

  1. Anaemia (lack of blood): 21 people, 43.75%
  2. Pain: 20 people, 41.67%
  3. Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 41.67%
  4. Thrombocytopenia (decrease of platelets in blood): 20 people, 41.67%
  5. Neoplasm Malignant (cancer tumour): 20 people, 41.67%
  6. Urinary Tract Infection: 19 people, 39.58%
  7. Stress And Anxiety: 18 people, 37.50%
  8. Bone Pain: 18 people, 37.50%
  9. Back Pain: 18 people, 37.50%
  10. Depression: 16 people, 33.33%

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 15 people, 31.25%
  2. Breast Cancer Metastatic: 12 people, 25.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.50%
  4. Neoplasm Malignant (cancer tumour): 5 people, 10.42%
  5. Breast Cancer: 5 people, 10.42%
  6. Bone Disorder: 5 people, 10.42%
  7. Adrenocortical Carcinoma (adrenal cortex cancer): 4 people, 8.33%
  8. Pain: 4 people, 8.33%
  9. Nausea (feeling of having an urge to vomit): 4 people, 8.33%
  10. Diarrhea: 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Prinivil and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prinivil:

Neoplasm progression treatments and more:

How severe was Neoplasm progression and when was it recovered:

Expand to all the drugs that have ingredients of lisinopril:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prinivil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Browse all the conditions that are associated with Neoplasm progression:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on lisinopril (the active ingredients of Prinivil) and Prinivil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.